6Lurati A,Teruzzi B,Salmaso A,et al.Macrophage activation syndrome (MAS) during anti-IL1 receptor therapy (anakinra) in a patient affected by systemic onset juvenile idiopathic arthritis (soJIA).Pediatr Rheumatol Online J,2005,3(2):79-85.
7Sadahiro T,Hirasawa H,Oda S,et al.Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure.Crit Care Med,2001,29:1386-1392.
4Groin AA, Villanueva J, Lee S, et al. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr, 2003, 142: 292- 296.
5Emmenegger U, Reimers A, Frey U, et al. Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly, 2002, 132: 230- 236
6Henter JI, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol, 2004, 50: 157-174.
7Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologie manifestations in juvenile rheumatoid arthritis: possible relation to drug or infection. J Pediatr, 1985, 106: 561- 566.
8Groin AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curt Opin Rheumatol, 2003, 15: 587-590.
9Arlet JB, LE Thi Huong D, Marinho A, et al. Reactive haemophagocytic syndrome in adult onset Still's disease: report of 6 patients and review of the literature. Ann Rheum Dis, 2006, 65: 1596-1601.
10Lambotte O, Cacoub P, Costedoat N, et al. High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. J Rheumatol, 2003, 30: 1027-1028.
